Winnipeg is about to have the first acute-care hospital in Canada that offers free life-saving products from a vending machine.

It has been about a month since the last earnings report for Idexx Laboratories (IDXX). Shares have lost about 5% in that time frame, underperforming the S&P 500.

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion amidst recent challenges. Read the full stock report here.

Idexx Labs' fourth-quarter results easily surpassed analysts' expectations. However, its even stronger guidance for 2025 may have stolen the show. Set to launch its newest diagnostic instrument in ...

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price increases.

IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Mr. McKeon will serve as EVP and ...

IDEXX Laboratories trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits to veterinary clinics from pet owners.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results Th ...

WESTBROOK, Maine (AP) — WESTBROOK, Maine (AP) — Idexx Laboratories Inc. (IDXX) on Tuesday reported second-quarter profit of $203.3 million. On a per-share basis, the Westbrook… ...

IDEXX's (IDXX) new Catalyst Pancreatic Lipase Test is likely to support veterinarians globally in diagnosing pancreatitis.

IDEXX has experienced double-digit growth in consumables, software, and diagnostic imaging. Check out why I downgrade IDXX stock from hold to sell.